Gene · 10818
Papers1,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of the folding and binding properties of the PTB domain of FRS2 with phosphorylated and unphosphorylated ligands. | Arch Biochem Biophys | 2023 | 37543351 | PubTator, text mining | PubMed |
| CDK4/6 Inhibitor Resistance in Hormone Receptor-Positive Metastatic Breast Cancer: Translational Research, Clinical Trials, and Future Directions. | Int J Mol Sci | 2023 | 37511548 | PubTator, text mining | PubMed |
| Revisiting the Role of Autophagy in Cardiac Differentiation: A Comprehensive Review of Interplay with Other Signaling Pathways. | Genes (Basel) | 2023 | 37510233 | PubTator, text mining | PubMed |
| Retracted: TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway. | Evid Based Complement Alternat Med | 2023 | 37501839 | PubTator, text mining | PubMed |
| Current progress in cancer treatment by targeting FGFR signaling. | Cancer Biol Med | 2023 | 37493315 | PubTator, text mining | PubMed |
| Beyond canonical PROTAC: biological targeted protein degradation (bioTPD). | Biomater Res | 2023 | 37480049 | PubTator, text mining | PubMed |
| Tackling FGFR3-driven bladder cancer with a promising synergistic FGFR/HDAC targeted therapy. | NPJ Precis Oncol | 2023 | 37479885 | PubTator, text mining | PubMed |
| Defining critical illness using immunological endotypes in patients with and without sepsis: a cohort study. | Crit Care | 2023 | 37474944 | PubTator, text mining | PubMed |
| Expression of fibroblast growth factor receptor substrate 2 (FRS2) in primary retroperitoneal liposarcoma and its clinical implications. | Eur Rev Med Pharmacol Sci | 2023 | 37458641 | PubTator, text mining | PubMed |
| The combined action of the intracellular regions regulates FGFR2 kinase activity. | Commun Biol | 2023 | 37452126 | PubTator, text mining | PubMed |
| Partial inhibition of class III PI3K VPS-34 ameliorates motor aging and prolongs health span. | PLoS Biol | 2023 | 37432924 | PubTator, text mining | PubMed |
| Neuroprotective Role of Klotho on Dementia. | Cureus | 2023 | 37425590 | PubTator, text mining | PubMed |
| Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. | Mol Cancer | 2023 | 37415164 | PubTator, text mining | PubMed |
| Accumulated X-ray irradiation induces miR-187-5p upregulation mediating fibrotic buccal mucosal fibroblasts activities via DKK2. | J Dent Sci | 2023 | 37404627 | PubTator, text mining | PubMed |
| Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGS. | BMC Cancer | 2023 | 37400763 | PubTator, text mining | PubMed |
| Mutational spectrum for guiding the decision of adjuvant treatment in patients with resected biliary tract carcinoma. | Cancer Med | 2023 | 37341068 | PubTator, text mining | PubMed |
| Deciphering transcriptional dynamics of cardiac hypertrophy and failure in a chamber-specific manner. | Biomol Biomed | 2023 | 37334749 | PubTator, text mining | PubMed |
| HIF-1-Induced hsa-miR-429: Understanding Its Direct Targets as the Key to Developing Cancer Diagnostics and Therapies. | Cancers (Basel) | 2023 | 37296866 | PubTator, text mining | PubMed |
| S-Palmitoylation during Retinoic Acid-Induced Neuronal Differentiation of SH-SY5Y Neuroblastoma Cells. | J Proteome Res | 2023 | 37294931 | PubTator, text mining | PubMed |
Clinical and Genomic Characteristics of Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 Inhibitors. | Clin Cancer Res | 2023 | 37289194 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10818/papers?page=6